Introduction
 Thyroid tumors of uncertain malignant potential (TT-UMP) has been accepted as a subgroup of follicularpatterned thyroid tumors for which benignancy or malignancy cannot be assessed exactly. We aimed to evaluate demographic characteristics, ultrasound (US) findings, and cytological results of patients with TT-UMP and compare these findings with the classical variant of papillary thyroid carcinoma (CV-PTC) and nonencapsulated follicular variant of PTC (NEFV-PTC) patients, and also to evaluate the immunohistochemical characteristics of patients with TT-UMP.
.
Methods
 Twenty-four patients with TT-UMP, 672 with CV-PTC, and 132 with NEFV-PTC were included to the study. .
Results
 Mean longitudinal nodule size and median nodule volume were higher in TT-UMP group compared to CV-PTC and NEFV-PTC groups (p<0.001 and p<0.001 for CV-PTC; p<0.001 and p=0.008 for NEFV-PTC).  Presence of halo and peripheral vascularization were observed more frequently in TT-UMP group compared to CV-PTC group (p=0.002 and p=0.024). Nodule localization, texture, echogenicity, presence of microcalcification, and presence of macrocalcification were similar in TT-UMP and CV-PTC groups (Table 1) .  US findings and cytological results were similar in TT-UMP and NEFV-PTC groups (all, p>0.05) ( Table 2) .  Benign and follicular neoplasm/suspicious for follicular neoplasm cytological results were higher in TT-UMP group compared to CV-PTC group (p=0.030 and p=0.001).  Median tumor size was higher in TT-UMP group than CV-PTC and NEFV-PTC groups (25 mm vs 6 mm, p<0.001 and 25 mm vs 14.4 mm, p=0.006, respectively).  In TT-UMP group, positive expression of HBME-1, CK-19 and Gal-3 was found as 50%, 33.3% , and 25%, respectively.
Conclusion  This study demonstrated that patients with TT-UMP had higher nodule and tumor size compared to CV-PTC and NEFV-PTC patients. Moreover, we found that US features and cytological results were similar in NEFV-PTC and TT-UMP patients.
